NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - Alamar Biosciences, Inc. - 5.03 / 8.01 / 9.01

Filed: 2026-04-20 AccNo: 0001193125-26-163921 Size: 184 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
发布时间04/20 20:02 UTC
首次发现04/20 20:06 UTC
热度104.7
重要度58
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 857 字符

Form 8-K - Current report: SEC Accession No. 0001193125-26-163921

Filing Date: 2026-04-20

Accepted: 2026-04-20 16:02:39

Documents: 12

Period of Report: 2026-04-20

Items: Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Alamar Biosciences, Inc. (Filer) CIK : 0002104204 (see all company filings) EIN. : 364899036 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-43235 | Film No.: 26875014 SIC : 3826 Laboratory Analytical Instruments (CF Office: 08 Industrial Applications and Services)

1 | 8-K | d103481d8k.htm iXBRL | 8-K

2 | EX-3.1 | d103481dex31.htm | EX-3.1

3 | XBRL TAXONOMY EXTENSION SCHEMA | almr-20260420.xsd | EX-101.SCH

4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | almr-20260420_lab.xml | EX-101.LAB